Basic & Clinical Medicine ›› 2019, Vol. 39 ›› Issue (2): 197-202.

Previous Articles     Next Articles

TRPV4 agonist 4α-PDD alleviates cerebral ischemia/reperfusion injury in rats

  

  • Received:2018-07-02 Revised:2018-09-28 Online:2019-02-05 Published:2019-01-16

Abstract: Objective To tested whether the endothelial transient receptor potential cation channel subfamily V member 4 (TRPV4) activation could improve functional recovery in rats subjected to brain ischemia/reperfusion and its mechanisms. Methods 30 SD rats were randomly divided into Sham group, middle cerebral artery occlusion(MCAO)group and 4α-PDD group. The volume of cerebral infarction was detected by TTC method;the degree of nerve injury was evaluated by Garcia score; the expression of endothelial nitric oxide synthase (eNOS), VEGF receptor -2 (VEGFA-2) and vascular endothelial growth factor A (VEGFA) mRNA were detected by quantitative RT-PCR; CD3 and Sox2 proteins were detected by immunohistochemistry. Results Compared with Sham group, the volume of cerebral infarction and neurological deficit in MCAO group increased significantly (P < 0.001). 4α-PDD reduced infarct volume (p < 0.001) and improved functional outcomes (p < 0.05) on day 3 after MCAO.TRPV4 activation significantly increased endothelial nitric oxide synthase(eNOS) expression in the ischemic region(p < 0.001). The expressions of vascular endothelial growth factor A (VEGFA) and VEGF receptor-2 were significantly higher in the 4α-PDD group(p < 0.001). 4α-PDD treatment also caused a significantly increase of microvessel density (p < 0.001). In addition, Neural progenitor cells (NPC) proliferation and migration in the ischemic hemisphere were increased, respectively. Conclusion TRPV4 activation by 4α-PDD may improve functional recovery through angiogenesis and neurogenesis after MCAO.